LUTS include storage symptoms such as nocturia and incontinence; voiding symptoms such as weak stream, and terminal dribble; and post-micturition symptoms such as incomplete emptying. These have a significant negative effect on patients’ quality of life with both psychological and physical health consequences. Following the general practitioner, the office urologist is usually the first specialist physician these patients are referred to.
European office urologists work on a broad spectrum of urological conditions with roles varying per country. The EAU Section of Urologists in Office (ESUO) has organised a meeting to bring together these urologists, encourage scientific discussions, bridge differences, and ultimately enhance their clinical practice. This meeting aims to guide participants through the current EAU Guidelines on LUTS diagnostics and conservative/drug treatment.
Expert speakers will address stressful urological conditions such as interstitial cystitis and “painful voiding” in female. They will examine new combination drug treatments in non-neurogenic LUTS, and patient adherence to LUTS pharmacological therapy.
The meeting will also underline the hazards of fluoroquinolones due to their widespread use for urinary tract infections, and the increased microbe resistance existing in some European countries.
Participants can look forward to a broader framework for assessing LUTS pathophysiology and management aimed to be developed and integrated into clinical practice or research. The meeting will present new emerging technologies including the Low Intensity Shock Wave as a potential new office-based treatment for LUTS; and will briefly discuss LUTS’ association with erectile dysfunction.
In addition, a presentation on the unmet needs of office urologists will explain the reasons why patients abandon drug therapy for overactive bladder.
Share this on your favourite network: